a
a
- Home
- a
-
-
29 MAY 14
- 0 comments
-
- Launch of PRECISESADS in Spain – El Pais Interview 6414 2014-03-17T09:06:09+00:00
- PRECISESADS Kick off meeting, Brussels, 18-19th February 2014 5709 2014-02-18T16:02:55+00:00
- Annual General Assembly Meeting – Berlin, Feb 2015 4000 2015-01-19T09:40:02+00:00
- PRECISESADS Press Release 3233 2014-02-18T10:28:21+00:00
- PRECISESADS & AETIONOMY Projects Joint Workshop 2981 2014-08-08T10:42:02+00:00
Photostream
Precisesads
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases
-
by phone: +34 958 715 500
-
by e-mail:
-
or fill in the form on contact page
- IMI
- European Union
- EFPIA
This website reflects only the author’s views and neither IMI nor the European Commission are liable for any use that may be made of the information contained therein.
PRECISESADS receives support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n° [115565], resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution.
PRECISESADS
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases
-
P. T. Ciencias de la Salud Avda. de la Ilustración 114Telf. +34 958 715 500 (ext 202)
-
18016 Granada, SpainFax +34 958 637 071
© Copyright - Precisesads. All rights reserved.
Leave a reply